Citation, DOI and article data
Schwannomas, less commonly called neurinomas or neurilemmomas, are benign tumors of Schwann cell origin and are the most common tumor of peripheral nerves, including cranial nerves.
This article provides a general overview of schwannomas. For a discussion of schwannomas located at specific sites, please refer to the relevant articles listed below.
Peak presentation is in the 5th-6th decades. When they occur in patients with neurofibromatosis type 2 (NF2), schwannomas usually present by the 3rd decade 4. There is no sex predilection.
Most schwannomas are solitary (90%) 2 and sporadic, however, there is an association with NF2 (abnormality of chromosome 22). Multiple schwannomas are characteristic of NF2. Approximately 18% of solitary schwannomas occur in patients with NF2 4.
There is also schwannomatosis, which consists of multiple schwannomas without the concomitant involvement of cranial nerve VIII.
Presentation depends on the location of the tumor (see below) but generally, symptoms are due to local mass effect or dysfunction of the nerve they arise from.
Schwannomas are benign encapsulated neoplasms of Schwann cells (WHO grade I). They arise eccentrically from their parent nerve, with the nerve fibers splayed along their surface (as distinct to neurofibromas which arise within the nerve).
Conventional schwannomas are composed of spindle cells which demonstrate two growth patterns: Antoni type A and Antoni type B 7,8.
Antoni type A pattern: elongated cells are densely packed and arranged in fascicles. Palisades are sometimes seen; when prominent these form Verocay bodies.
Antoni type B pattern cells are less compact and are prone to cystic degeneration.
Schwannoma variants include 6,8:
- ancient schwannoma
- cellular schwannoma
- predominantly composed of Antoni A tissue
- no Verocay bodies
- most commonly found in a paravertebral location, or trigeminal nerves (CN V)
- melanotic schwannoma: dense melanin pigment
- plexiform schwannoma
- cranial nerves: although almost any cranial nerve may be involved, except olfactory nerves and optic nerves which lack sheaths composed of Schwann cells, by far the most commonly involved nerve is the vestibulocochlear nerve (CN VIII)
- non-cranial nerve or intracerebral (very rare)
- arising from spinal nerve roots
- especially flexor surfaces (specifically ulnar and peroneal nerves)
General imaging features of schwannomas include:
- well-circumscribed masses which displace adjacent structures without direct invasion
- cystic and fatty degeneration is common 4
- the larger a schwannoma, the more likely it is to show heterogeneity because of cystic degeneration or hemorrhage 3
- hemorrhage occurs in 5% of cases 3
- calcification is rare
CT is not as sensitive or specific for the diagnosis of schwannoma as MRI but is often the first investigation obtained. It is particularly useful in assessing bony changes adjacent to the tumor.
Imaging features include:
- low to intermediate attenuation
- intense contrast enhancement
- small tumors typically demonstrate homogeneous enhancement
- larger tumors may show heterogeneous enhancement
- adjacent bone remodeling with smooth corticated edges
Schwannomas have fairly predictable signal characteristics 7:
- T1: isointense or hypointense
- T1 C+ (Gd): intense enhancement
T2: heterogeneously hyperintense (Antoni A: relatively low, Antoni B: high)
- cystic degenerative areas may be present, especially in larger tumors
- T2*: larger tumors often have areas of hemosiderin
A number of signs can also be useful:
- split-fat sign: thin peripheral rim of fat best seen on planes along long axis of the lesion in non-fat-suppressed sequences
- peripheral high T2 signal
- central low signal
- rarely seen intracranially 7
- fascicular sign: multiple small ring-like structures
Treatment and prognosis
Schwannomas are slow-growing lesions. Surgery is the treatment of choice. As schwannomas do not infiltrate the parent nerve, they can usually be separated from it. Recurrence is unusual, after complete resection. They almost never undergo malignant change.
- 1. Beaman FD, Kransdorf MJ, Menke DM. Schwannoma: radiologic-pathologic correlation. Radiographics. 24 (5): 1477-81. doi:10.1148/rg.245045001 - Pubmed citation
- 2. Weissleder R, Wittenberg J, M.D. MG et-al. Primer of Diagnostic Imaging, Expert Consult- Online and Print. Mosby. (2011) ISBN:0323065384. Read it at Google Books - Find it at Amazon
- 3. Brant WE, Helms CA. Fundamentals of Diagnostic Radiology. Lippincott Williams & Wilkins. (2007) ISBN:0781761352. Read it at Google Books - Find it at Amazon
- 4. Osborn AG. Diagnostic neuroradiology. Mosby Inc. (1994) ISBN:0801674867. Read it at Google Books - Find it at Amazon
- 5. Murphey MD, Smith WS, Smith SE et-al. From the archives of the AFIP. Imaging of musculoskeletal neurogenic tumors: radiologic-pathologic correlation. Radiographics. 19 (5): 1253-80. Radiographics (citation) - Pubmed citation
- 6. Kurtkaya-Yapicier O, Scheithauer B, Woodruff JM. The pathobiologic spectrum of Schwannomas. Histol. Histopathol. 2004;18 (3): 925-34. Pubmed citation
- 7. Skolnik AD, Loevner LA, Sampathu DM et-al. Cranial Nerve Schwannomas: Diagnostic Imaging Approach. Radiographics. 2016;36 (5): 150199. doi:10.1148/rg.2016150199 - Pubmed citation
- 8. Louis DN, Ohgaki H, Wiestler OD et-al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114 (2): 97-109. Acta Neuropathol. (full text) - doi:10.1007/s00401-007-0243-4 - Free text at pubmed - Pubmed citation